• Eli Lilly's earnings, sales guidance for 2020 tops estimates firstwordpharma
    December 17, 2019
    Eli Lilly said Tuesday that it expects earnings per share next year in the range of $6.70 to $6.80, with overall revenue between of $23.6 billion and $24.1 billion, driven by growth from key products such as Taltz and Trulicity.
PharmaSources Customer Service